HCPCS Level IIdrugActive
J1813
Lyumjev for insulin pump use
BETOS: D1G
Effective: 2024-01-01
Referenced in 3 policies
Description
Insulin (lyumjev) for administration through dme (i.e., insulin pump) per 50 units
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Lyumjev
Manufacturer
Eli Lilly and Company
HCPCS Dosage
50 UNITS
Billing Units
20.0000
2
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.